Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3911-3920 Newer>

The Motley Fool July 26, 2007 Brian Orelli	Barr Gets Sued, Again This is starting to be a bad habit at Barr Pharmaceutical. The drug maker has just been sued for the third time in as many weeks. The latest one is by Schering-Plough, over patent infringement of its brain cancer treatment drug.
The Motley Fool July 26, 2007 Brian Lawler	Flamel Gets Stomped by GSK Shares of Flamel fall as its partner doesn't focus on marketing its lead drug.
The Motley Fool July 25, 2007 Brian Orelli	Shiny Happy Illumina Illumina, which makes chips that can distinguish one million different genes, announced another stellar quarter. That makes eight in a row.
The Motley Fool July 25, 2007 Brian Lawler	Vertex Is on Its Way Vertex Pharmaceuticals is still years away from any regulatory approval on telaprevir in the U.S., but highlights promising results so far in its quarterly report.
The Motley Fool July 25, 2007 Brian Orelli	On to the FDA With a New Name After four phase 3 clinical trials, Advanced Magnetics is ready to submit a New Drug Application for ferumoxytol, and if all goes well, could have the product on the market by the end of next year.
The Motley Fool July 25, 2007 Brian Lawler	GPC Must Wait An advisory panel recommends against approving GPC's lead drug right now. Investors, take note.
The Motley Fool July 25, 2007 Ryan Fuhrmann	The Latest Procedure From Quest Diagnostics Quest Diagnostics took a hit earlier this year from the loss of a major contract, but the lab testing firm isn't down for the count.
The Motley Fool July 25, 2007 Billy Fisher	Dueling Fools: Intuitive Surgical Bull Rebuttal On the bull side, experience, coupled with the company's future earnings and revenue prospects, may indicate that Intuitive Surgical has yet to reach its zenith.
The Motley Fool July 25, 2007 Charly Travers	Dueling Fools: Intuitive Surgical Bear Rebuttal On the bear side, Intuitive Surgical cannot continue to grow at an annual rate to make its stock a good value.
The Motley Fool July 25, 2007	The Handle on Hansen Medical Investors, here is an interview with Frederic Moll, Hansen Medical's co-founder and CEO about the company's robotic catheter system, the advantages it offers, and growth opportunities.
<Older 3911-3920 Newer> Return to current articles.